Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Obesity Medicine
•
Primary Care
How do you decide whether to reinitiate a GLP-1 agonist after a patient has experienced acute pancreatitis while on this therapy?
Related Questions
How do you counsel patients on GLP-1 agonists for weight loss who wish to space out their medication or take a "drug holiday" to temporarily increase their appetite?
How do you counsel non-diabetic patients who wish to start metformin to reduce the risk of developing dementia?
How do you decide whether average-risk patients should undergo annual or biannual breast cancer screening?
When do you recommend referring a patient to a dietitian for malnutrition?
Should GLP-1 agonists be used to reduce the risk of dementia in patients with a family history?
What is your approach to duration of fidaxomicin in a patient receiving treatment for first C difficile infection while also receiving concurrent antibiotics for an infection?
How do you counsel patients about receiving multiple vaccinations at once versus spacing them out over time?
What is your preferred screening tool for colon cancer in an average-risk patient?
When do you recommend limited or targeted respiratory pathogen testing versus a full respiratory pathogen panel in a patient presenting with URI symptoms?
How do you approach the use of metformin in the management of prediabetes for patients who are neither obese nor have a family history of diabetes?
